Of the the assets sold, the documents said that at least $85 million “is directly attributable to Sacks.” The memo, from ...
Fintel reports that on March 14, 2025, Cantor Fitzgerald initiated coverage of Protara Therapeutics (NasdaqGM:TARA) with a Overweight recommendation. Analyst Price Forecast Suggests 559.70% Upside As ...
In a report released yesterday, Andres Sheppard from Cantor Fitzgerald initiated coverage with a Buy rating on Eve Holding (EVEX – Research ...
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...
Cantor Fitzgerald analyst Li Watsek initiated coverage of Protara Therapeutics (TARA) with an Overweight rating.Light Up your Portfolio with ...
Eric Johnston, chief equity and macro strategist at Cantor Fitzgerald, said he believes stocks are in for a tactical ...
Cantor Fitzgerald announced Anchorage Digital, Copper.co will serve as collateral managers and custodians for the firm's ...
Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, ...